Incidence Rates of COVID-19-Associated Hospitalization and Risk Factors for Severe Disease Among American Indian and Alaska Native Persons in the Southwest USA and Alaska
- PMID: 40691741
- DOI: 10.1007/s40615-025-02492-9
Incidence Rates of COVID-19-Associated Hospitalization and Risk Factors for Severe Disease Among American Indian and Alaska Native Persons in the Southwest USA and Alaska
Abstract
Introduction: COVID-19 causes significant morbidity in the USA, particularly among American Indian/Alaska Native (AI/AN) persons. Estimates of COVID-19 burden among AI/AN communities are needed to identify health outcome disparities and inform prevention strategies, but under-ascertainment of AI/AN status in national data may result in underestimation of COVID-19 disease burden.
Methods: Surveillance for acute respiratory illness was conducted among AI/AN persons at eight healthcare facilities in Arizona and Alaska to identify COVID-19-associated hospitalizations and outpatient visits. Weekly and annual incidence rates of COVID-19-associated hospitalizations per 100,000 persons were calculated overall and by site and age. Risk factors for COVID-19-associated hospitalizations (versus outpatient visits) were assessed.
Results: From January 2021 to December 2022, 1159 COVID-19-associated hospitalizations were identified. Incidence rates were 439.8 per 100,000 in 2021 and 332.6 per 100,000 in 2022 and highest among adults ≥ 65 years at all sites. Compared to national estimates from 2021 to 2022, incidence rates by time and age were similar among older adults, whereas incidence rates among AI/AN children were over twice as high. Among adults, older age, chronic lung disease, chronic kidney disease, and diabetes increased the risk of hospitalization; frequent mask use outside the home and COVID-19 vaccination were protective, particularly if vaccinated within the past year. Among children, younger age and heart conditions increased the risk of hospitalization.
Conclusions: The findings demonstrate a substantial burden of COVID-19 in AI/AN persons and provide critically needed data regarding the risks for severe outcomes. AI/AN children experience a disproportionate burden of COVID-19 disease.
Keywords: COVID-19; Indigenous health; Risk factor; SARS-CoV-2.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics Approval: This study was reviewed and approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board (IRB) and the ethics review board for each participating tribe (Arizona sites: Navajo Nation Human Research Review Board and Phoenix Area Indian Health Service IRB; Alaska sites: Alaska Area IRB, Alaska Native Tribal Health Consortium, Southcentral Foundation, and Yukon-Kuskokwim Health Corporation). This study was reviewed by the Centers for Disease Control and Prevention (CDC) and was conducted consistent with applicable federal law and CDC policy [62]. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guidelines [63]. Consent to Participate: Informed consent was obtained from all adult participants included in the study. Informed consent was obtained from the legal guardians of child participants included in the study, and assent was also obtained for child participants 7–17 years of age included in the study. Competing interests: CSL — none. CGS — research grants to her institution from Merck and Pfizer. JWK — none. RMH — none. CD — none. ASW — none. ABB — none. APC — none. LC — none. LC — none. SD — none. JD — none. SG — none. NH — none. EH — none. VL — none. MLM — none. DP — none. MMP — none. JR — none. PV — none. MV — none. DV — none. DY — none. RJS — none. LLH — research grants to her institution from AstraZeneca, Merck and Pfizer. Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention or the Indian Health Service.
Similar articles
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
-
Advancing Health Equity for American Indian and Alaska Native People Through Inclusion in Clinical Trials: Anti-SARS-CoV-2 Monoclonal Antibody Treatment and COVID-19 Outcomes Among Ambulatory Cherokee Nation Health Services Patients.Health Equity. 2025 Apr 21;9(1):235-244. doi: 10.1089/heq.2024.0185. eCollection 2025. Health Equity. 2025. PMID: 40677646 Free PMC article.
-
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2. Cochrane Database Syst Rev. 2023. Update in: Cochrane Database Syst Rev. 2023 May 15;5:CD014908. doi: 10.1002/14651858.CD014908.pub3. PMID: 36622724 Free PMC article. Updated.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
-
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46. J Manag Care Pharm. 2010. PMID: 20131495 Free PMC article.
References
-
- World Health Organization. WHO coronavirus (COVID-19) dashboard. Available online: https://covid19.who.int/ (accessed on 2024 May 23).
-
- Centers for Disease Control and Prevention. COVID-19 medical conditions. Available online: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-... (accessed on 2023 Jan 2).
-
- United States Census Bureau. Race and Ethnicity in the United States: 2010 Census and 2020 Census. Available online: https://www.census.gov/library/visualizations/interactive/race-and-ethni... (accessed on 2022 Jan 21).
-
- Golden SH, Yajnik C, Phatak S, Hanson RL, Knowler WC. Racial/ethnic differences in the burden of type 2 diabetes over the life course: a focus on the USA and India. Diabetologia. 2019;62:1751–60. https://doi.org/10.1007/s00125-019-4968-0 . - DOI - PubMed - PMC
-
- Hutchinson RN, Shin S. Systematic review of health disparities for cardiovascular diseases and associated factors among American Indian and Alaska Native populations. PLoS ONE. 2014;9:e80973. https://doi.org/10.1371/journal.pone.0080973 . - DOI - PubMed - PMC
Grants and funding
LinkOut - more resources
Miscellaneous